Covered recipient · General Payments record
NIRMEET RAI
General Payments · PY2018–2024
$1,868.19
- Reported across 73 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $356.13 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $233.32 | 18 |
| Lilly USA, LLC | $122.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $12.54 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038140 | CMS |
| Amgen Inc. | $10.97 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038134 | CMS |
| Amgen Inc. | $9.75 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038146 | CMS |
| Amgen Inc. | $14.81 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038152 | CMS |
| Amgen Inc. | $12.06 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038158 | CMS |
| Amgen Inc. | $5.55 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038164 | CMS |
| Amgen Inc. | $7.18 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038178 | CMS |
| Amgen Inc. | $8.96 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038186 | CMS |
| Amgen Inc. | $8.71 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038190 | CMS |
| Amgen Inc. | $16.80 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038194 | CMS |
| Amgen Inc. | $8.91 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038203 | CMS |
| Amgen Inc. | $13.85 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038210 | CMS |
| Amgen Inc. | $7.62 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038216 | CMS |
| Amgen Inc. | $9.22 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038222 | CMS |
| Amgen Inc. | $21.15 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038228 | CMS |
| Amgen Inc. | $18.55 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038236 | CMS |
| Amgen Inc. | $24.01 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038255 | CMS |
| Amgen Inc. | $22.68 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116038261 | CMS |
| Lilly USA, LLC | $122.81 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135241976 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.